<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30517252</article-id><article-id pub-id-type="pmc">6257533</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0070</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparison of the Efficacy of Oral <italic>versus</italic>
Intravascular Magnesium in the Prevention of Hypomagnesemia and Arrhythmia after
CABG</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jannati</surname><given-names>Mansour</given-names></name><role>MD</role><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Shahbazi</surname><given-names>Shahrbanoo</given-names></name><role>MD</role><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Eshaghi</surname><given-names>Laleh</given-names></name><role>MD</role><xref ref-type="aff" rid="aff3">3</xref></contrib></contrib-group><aff id="aff1">
<label>1</label> Cardiovascular Surgery Ward, Faghihi Hospital, Shiraz University of
Medical Sciences, Shiraz, Iran.</aff><aff id="aff2">
<label>2</label> Department of Anesthesiology, Shiraz Anesthesiology and Critical
and Care Research Center, Nemazee Hospital, Shiraz University of Medical Sciences,
Shiraz, Iran.</aff><aff id="aff3">
<label>3</label> Department of Anesthesiology, Shiraz University of Medical
Sciences, Shiraz, Iran.</aff><author-notes><corresp id="c1">Correspondence Address: Mansour Jannati, Department of Surgery,
Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. E-mail:
<email>mansour.jannati@mail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2018</year></pub-date><volume>33</volume><issue>5</issue><fpage>448</fpage><lpage>453</lpage><history><date date-type="received"><day>06</day><month>3</month><year>2018</year></date><date date-type="accepted"><day>19 </day><month>5</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>Cardiac arrhythmias are a common challenge following open-heart surgeries.
Hypomagnesemia is believed to be correlated with this condition.
Prophylactic intravenous magnesium supplementation has been practiced for a
long time in patients undergoing CABG. This study was designed in an attempt
to compare the efficacy of oral <italic>versus</italic> intravenous routes
in the prevention of hypomagnesemia and arrhythmia.</p></sec><sec><title>Methods</title><p>In this interventional clinical study, 82 patients were randomly assigned to
2 groups. All patients were evaluated for baseline serum magnesium level and
arrhythmias. One group received 1,600 mg of oral magnesium hydroxide through
nasogastric (NG) tube prior to surgery, while the other group received 2 g
of magnesium sulfate during the induction of anesthesia. The serum magnesium
level was monitored for 48 hours after the operation. The difference in
preoperative hypomagnesemia was non-significant (Sig: 0.576).</p></sec><sec><title>Results</title><p>During the operation, the serum magnesium level peaked around 4 mg/dL, and no
hypomagnesemia was detected in any patient. Although the curve of oral group
declined parallel and below that of intravenous (IV) group, no significant
differences were detected during postoperative monitoring. In addition, a
prevalence of arrhythmia of 13.9% and 6.5% was noticed in IV and oral
groups, respectively (OR: 0.428).</p></sec><sec><title>Conclusion</title><p>Providing 1,600 mg of oral magnesium supplement to patients is as effective
as 2,000 mg of magnesium sulfate IV in preventing hypomagnesemia and
arrhythmia after CABG. Thus, the authors introduce this treatment regimen as
a promising and cost-effective method.</p></sec></abstract><kwd-group><kwd>Coronary Artery Bypass</kwd><kwd>Magnesium Sulfate</kwd><kwd>Magnesium Hydroxide</kwd><kwd>Administration, Intravenous</kwd><kwd>Administration, Oral</kwd><kwd>Arrhythmias, Cardiac</kwd></kwd-group></article-meta></front><body><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AF</td><td align="left" rowspan="1" colspan="1">= Atrial fibrillation</td></tr><tr><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">= Coronary artery bypass graft</td></tr><tr><td align="left" rowspan="1" colspan="1">CAD</td><td align="left" rowspan="1" colspan="1">= Coronary artery disease</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB</td><td align="left" rowspan="1" colspan="1">= Cardiopulmonary bypass</td></tr><tr><td align="left" rowspan="1" colspan="1">ECG</td><td align="left" rowspan="1" colspan="1">= Electrocardiogram</td></tr><tr><td align="left" rowspan="1" colspan="1">IABP</td><td align="left" rowspan="1" colspan="1">= Intra-aortic balloon pump</td></tr><tr><td align="left" rowspan="1" colspan="1">ICU</td><td align="left" rowspan="1" colspan="1">= Intensive care unit</td></tr><tr><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">= Intravenous</td></tr><tr><td align="left" rowspan="1" colspan="1">NG</td><td align="left" rowspan="1" colspan="1">= Nasogastric</td></tr><tr><td align="left" rowspan="1" colspan="1">SUMS</td><td align="left" rowspan="1" colspan="1">= Shiraz University of Medical Sciences</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Patients undergoing open-heart surgeries, such as coronary artery bypass graft
(CABG), are prone to develop new-onset postoperative cardiac arrhythmias,
particularly atrial fibrillation (AF), with an incidence of approximately 20 to
50%<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Despite the overall
advances in surgical and anesthetic procedures, the trend has not shown any decrease
over the past years<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. This
condition usually occurs within 24 to 96 hours after surgery<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup> and, due to its benign and
self-limiting course, no long-term sequelae are expected<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. However, the burden of associated complications
cannot be overlooked. AF predisposes patients to hemodynamic disturbance as a result
of reduced cardiac output and elevated atrial and ventricular end-diastolic
pressures<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Other
complications include thromboembolism, stroke and palpitations, which eventually
lead to prolonged hospital stay and increased costs<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Thus, these adverse clinical and financial
outcomes justify the excessive efforts made to improve preventive measures and
management guidelines.</p><p>There are numerous risk factors attributed to postoperative cardiac arrhythmia.
Hypomagnesemia has long been regarded as having a well-documented contributory role.
Supporting evidence arises from reports of arrhythmias in patients with low serum
magnesium levels (less than 1.5 mEq/L) and suppression of arrhythmias through
magnesium replacement<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Patients
with severe coronary artery disease are more likely to have magnesium deficiency. In
addition, cardiac surgery further exacerbates this disadvantage, in which a decline
is often detected on the first day after CABG, before a gradual rise to preoperative
levels by the fourth day<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>.
Therefore, prophylactic magnesium therapy is a common practice aimed at alleviating
this undesirable condition.</p><p>The present study pursues a twofold purpose; one is evaluating the efficacy of oral
<italic>versus</italic> intravascular magnesium administration in preventing
postoperative hypomagnesemia in patients undergoing CABG surgery and the second goal
is examining the potential of oral supplementation to prevent arrhythmias. To the
best of our knowledge, there is no similar experiment in the literature comparing
oral and intravascular routes of administration.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This interventional clinical study was conducted on 82 patients with coronary artery
disease (CAD), who were scheduled for CABG operation in hospitals affiliated with
Shiraz University of Medical Sciences (SUMS), Shiraz, Iran, during the year 2015.
Exclusion criteria consisted of history of renal diseases, liver diseases,
arrhythmias non-responsive to medical treatment and hypersensitivity to magnesium.
In addition, consumption of magnesium-containing medications, antiarrhythmic drugs,
beta-blockers, calcium channel blockers, and diuretics was regarded as another
exclusion criterion. Additionally, patients who underwent exploratory surgery after
CABG operation due to bleeding, or had intra-aortic balloon pump (IABP) insertion
were eventually omitted from the study. The Ethics Committee of SUMS approved all
the processes in this study.</p><p>Prior to surgery, each patient was fully instructed on the method of the study and
was required to fill out an informed written consent. Patients were equally
randomized to the oral or intravenous (IV) group, using the blocking method.
Subsequently, baseline magnesium level and electrocardiographic study were obtained.
All operations were performed by the same cardiac surgeon and both patients and
medical staff were blinded about the groupings. The sample size was calculated in at
least 36 subjects for each group (&#x000b5;1- &#x000b5;2 = 0.02, &#x003ed; = 0.03, 1-&#x003b2;
= 80%) and a <italic>P</italic>-value &#x0003c;0.05 was considered significant.</p><p>One group received 1,600 mg oral magnesium hydroxide (400 mg = 5 cc) through
nasogastric (NG) tube before the operation, while the other group received 2 g of
magnesium sulfate IV during the induction of anesthesia. General anesthesia was
administered with 0.1-0.2 mg/kg midazolam, 0.7-1 mg/kg sufentanil, 1-2 mg/kg sodium
thiopental and 0.2 mg/kg pancuronium. Anesthesia was maintained by propofol during
the surgery. Blood samples were immediately obtained, for a second time, after
induction of anesthesia. After sternotomy, the graft (internal thoracic artery,
saphenous vein or radial artery) was resected. Cannulation was made by the surgeon
and the patient was connected to the cardiopulmonary pump. The aorta was clamped and
cardioplegia solution was injected through the cannula. This solution contains 16 g
of magnesium. Meanwhile, the patient was cooled down to 34&#x000b0;C. After anastomosis, the
patient was warmed up again. At this time, another serum sample was collected.
Afterwards, 2 g of magnesium bolus was administered for both groups through
cardiopulmonary pump. In case of occurrence of arrhythmia after declamping, types
and treatments were recorded. Finally, the proximal anastomosis was performed. After
chest tube insertion and a thorough emulation for bleeding, the sternum was sutured.
Three other serum samples were collected when the patients were transferred to
intensive care unit (ICU), and 12 and 24 hours after transfer. Magnesium levels
below 2 mg/dL are considered as hypomagnesemia. Data were analyzed by IBM SPSS
Statistics using independent T-test and chi-square test. The results are
demonstrated descriptively and analytically.</p></sec><sec sec-type="results"><title>RESULTS</title><p>Initially 82 patients were involved in this study; however, 15 were subsequently
omitted due to exploratory surgery for bleeding or IABP insertion. The remainder
were 31 (53%) patients in IV group and 36 (46%) in the oral group (<xref rid="t1" ref-type="table">Table 1</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic and perioperative data in both IV and oral groups.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">IV Mg</th><th align="center" rowspan="1" colspan="1">Oral Mg</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value (Sig. &#x0003c;0.05)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">64.11&#x000b1;11.518</td><td align="center" rowspan="1" colspan="1">63.06&#x000b1;9.609</td><td align="center" rowspan="1" colspan="1">0.179</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (male)</td><td align="center" rowspan="1" colspan="1">71.4%</td><td align="center" rowspan="1" colspan="1">72.2%</td><td align="center" rowspan="1" colspan="1">0.938</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (female)</td><td align="center" rowspan="1" colspan="1">28.6%</td><td align="center" rowspan="1" colspan="1">27.8%</td><td align="center" rowspan="1" colspan="1">0.938</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">67.83&#x000b1;11.175</td><td align="center" rowspan="1" colspan="1">65&#x000b1;11.578</td><td align="center" rowspan="1" colspan="1">0.729</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiopulmonary bypass duration (min)</td><td align="center" rowspan="1" colspan="1">77.72&#x000b1;14.65</td><td align="center" rowspan="1" colspan="1">82.55&#x000b1;13.66</td><td align="center" rowspan="1" colspan="1">0.131</td></tr><tr><td align="left" rowspan="1" colspan="1">Cross-clamp duration (min)</td><td align="center" rowspan="1" colspan="1">42.61&#x000b1;11.27</td><td align="center" rowspan="1" colspan="1">45.61&#x000b1;9.99</td><td align="center" rowspan="1" colspan="1">0.329</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardioplegia volume (mL)</td><td align="center" rowspan="1" colspan="1">1353.61&#x000b1;344</td><td align="center" rowspan="1" colspan="1">1337.10&#x000b1;227</td><td align="center" rowspan="1" colspan="1">0.909</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypomagnesemia</td><td align="center" rowspan="1" colspan="1">2.8%</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative arrhythmia</td><td align="center" rowspan="1" colspan="1">11.9%</td><td align="center" rowspan="1" colspan="1">5.6%</td><td align="center" rowspan="1" colspan="1">0.442</td></tr><tr><td align="left" rowspan="1" colspan="1">ICU stay (hour)</td><td align="center" rowspan="1" colspan="1">109.33&#x000b1;110.533</td><td align="center" rowspan="1" colspan="1">102.97&#x000b1;122.053</td><td align="center" rowspan="1" colspan="1">0.498</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>ICU=intensive care unit</p></fn></table-wrap-foot></table-wrap><p>The serum magnesium level of both groups up to 48 hours after the operation is shown
in the chart below (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p><fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Serum magnesium level of both groups up to 48 hours after the
operation.</p><p>CPB=cardiopulmonary bypass, IV=intravenous; Pre op=preoperative
period</p></caption><graphic xlink:href="rbccv-33-05-0448-g01"/></fig></p><p>The original magnesium level in the orally treated group was 2.0339&#x000b1;0.7772
mg/dL, compared to the magnesium level in the parenteral group; 1.9708&#x000b1;0.6678
mg/dL. The difference in preoperative hypomagnesemia was non-significant in both
groups (<italic>P</italic>-value =0.576) (<xref rid="t2" ref-type="table">Table
2</xref>). During the operation, the curve rises to about 3.7 to 4 mg/dL, which
is predictable with regard to perioperative administration of magnesium. No
hypomagnesemia was detected in the groups during the operation and cardiopulmonary
bypass (CPB). Afterwards, it gradually declines, but with a faster inclination
during the first 12 hours. During this period, the magnesium level of oral group is
lower, but parallel to IV group. Generally, patients in both groups presented
hypomagnesemia without significant differences.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Prevalence of hypomagnesemia before, during and after the operation in both
IV and oral groups.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">IV (n=31)</th><th align="center" rowspan="1" colspan="1">Oral (n=36)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Preoperative&#x000a0;</td><td align="center" rowspan="1" colspan="1">16.7%</td><td align="center" rowspan="1" colspan="1">22.2%</td><td align="center" rowspan="1" colspan="1">0.576</td></tr><tr><td align="left" rowspan="1" colspan="1">During CBP</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Postop (0 hour)</td><td align="center" rowspan="1" colspan="1">2.8%</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Postop (12 h)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">3.2%</td><td align="center" rowspan="1" colspan="1">0.463</td></tr><tr><td align="left" rowspan="1" colspan="1">Postop (24 h)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">3.2%</td><td align="center" rowspan="1" colspan="1">0.463</td></tr><tr><td align="left" rowspan="1" colspan="1">Postop (48 h)</td><td align="center" rowspan="1" colspan="1">2.8%</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>CPB=cardiopulmonary bypass</p></fn></table-wrap-foot></table-wrap><p>In addition, a prevalence of preoperative arrhythmia of 13.9% and 6.5% was observed
in IV and oral groups, respectively (OR: 0.428). However, during the operation,
patients in oral group have the advantage, until the postoperative period, when both
presented the same prevalence (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p><p><fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Prevalence of arrhythmia in oral and IV groups.</p><p>CPB=cardiopulmonary bypass, IV=intravenous</p></caption><graphic xlink:href="rbccv-33-05-0448-g02"/></fig></p><p>The percentages of different types of arrhythmias are described in the <xref ref-type="fig" rid="f3">Figures 3</xref> and <xref ref-type="fig" rid="f4">4</xref>.</p><p><fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Arrhythmia in oral group.</p><p>AF=atrial fibrillation; AV Block=atrioventricular node block;
PAC=premature atrial contraction; PVC=premature ventricular contraction;
ST=sinus tachycardia</p></caption><graphic xlink:href="rbccv-33-05-0448-g03"/></fig></p><p><fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Arrhythmia in IV group.</p><p>AF=atrial fibrillation; AV Block=atrioventricular node block;
PAC=premature atrial contraction; PVC=premature ventricular contraction;
ST=sinus tachycardia</p></caption><graphic xlink:href="rbccv-33-05-0448-g04"/></fig></p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Magnesium is a bivalent cation essential for the maintenance of physiological
transmembrane gradients of sodium and potassium ions<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. It acts as a cofactor of the energy source for
contractility, adenosine-triphosphatase, and protects the myocardium against
ischemic reperfusion injury<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Serum magnesium concentration
decreases after cardiac surgery, which is usually normalized after 3 to 5
days<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>This deficiency leads to cardiovascular clinical manifestations such as hypertension
and electrocardiogram (ECG) changes, as well as supraventricular and ventricular
arrhythmias<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. Several
mechanisms have been proposed regarding the role of magnesium deficiency in
postoperative AF, but no clear explanation has been fully agreed upon. Some refer to
hemodilution, extracellular to intracellular shift, use of intraoperative diuretics,
increased urinary loss and catecholamine discharge, and high level of
epinephrine<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>Magnesium treatment has been shown to decrease the incidence of cardiac arrhythmias
by prolongation of the refractory period<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>]</sup>. Despite the
extensive investigation, a great lack of consistency is seen in the literature
regarding prophylactic magnesium therapy. In addition, indications, dosage and time
should be clarified. Conventional methods involve systemic and supplementation of
cardioplegic solution<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. The new
point of the present study is the application of oral route for the first time and
similar previous experiments are nonexistent. In addition, as the results indicated,
preoperative oral magnesium loading has a potential promising efficacy.</p><p>Several studies strongly encourage the preoperative loading of magnesium as a
suitable alternative agent in the prevention of postoperative arrhythmia, observing
its low cost and safety<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r12" ref-type="bibr">12</xref>-<xref rid="r16" ref-type="bibr">16</xref>]</sup>. This is in accordance with the recommendations of
European and Canadian guidelines<sup>[<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>]</sup>. However, this
is contrary to the recent US guideline, which did not mention magnesium as a choice
of routine management, along with other studies, which report only minimal benefit
or lack of any particular advantages<sup>[<xref rid="r19" ref-type="bibr">19</xref>-<xref rid="r22" ref-type="bibr">22</xref>]</sup>. Overall, it
seems that variety in design and quality of studies can be responsible for the
conflicting results. Nonetheless, the findings of the present study indicate that in
the settings mentioned in the study, oral and IV magnesium can be of equal
value.</p><sec><title>Limitation</title><p>Limitations and suggestions: studies with larger samples and use of a control
group.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Providing patients with 1,600 mg oral magnesium supplement is as effective as 2,000
mg of magnesium sulfate IV in preventing hypomagnesemia and arrhythmia after CABG.
Thus, authors suggest that this treatment regimen is promising.</p><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">MJ</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; agreement to be accountable for all aspects of the
work in ensuring that questions related to the accuracy or integrity
of any part of the work are appropriately investigated and resolved;
final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">SS</td><td align="left" rowspan="1" colspan="1">Drafting the work or revising it critically for
important intellectual content; agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">LE</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately investigated and resolved;
final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Department of Surgery, Faghihi Hospital, Shiraz
University of Medical Sciences, Shiraz, Iran.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>MF</given-names></name><name><surname>Herle</surname><given-names>A</given-names></name><name><surname>Movahed</surname><given-names>M Reza</given-names></name></person-group><article-title>Risk factors for post-coronary artery bypass grafting (CABG)
atrial fibrillation and the role of aspirin and beta blockers in its
prevention</article-title><source>J Atr Fibrillation</source><year>2013</year><volume>5</volume><issue>5</issue><fpage>800</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">28496818</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>WJ</given-names></name><name><surname>Wu</surname><given-names>ZJ</given-names></name><name><surname>Wang</surname><given-names>PF</given-names></name><name><surname>Aung</surname><given-names>LH</given-names></name><name><surname>Yin</surname><given-names>RX</given-names></name></person-group><article-title>Intravenous magnesium prevents atrial fibrillation after coronary
artery bypass grafting: a meta-analysis of 7 double-blind,
placebo-controlled, randomized clinical trials</article-title><source>Trials</source><year>2012</year><volume>13</volume><fpage>41</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">22520937</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahin</surname><given-names>V</given-names></name><name><surname>Kaplan</surname><given-names>M</given-names></name><name><surname>Bilsel</surname><given-names>S</given-names></name><name><surname>Filizcan</surname><given-names>U</given-names></name><name><surname>Cetemen</surname><given-names>S</given-names></name><name><surname>Bayserke</surname><given-names>O</given-names></name><etal/></person-group><article-title>The relation between blood and tissue magnesium levels and
development of atrial fibrillation after coronary artery bypass
surgery</article-title><source>Anadolu Kardiyol Derg</source><year>2010</year><volume>10</volume><issue>5</issue><fpage>446</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">20929703</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Archbold</surname><given-names>RA</given-names></name><name><surname>Zaman</surname><given-names>AG</given-names></name><name><surname>Archbold</surname><given-names>R</given-names></name></person-group><article-title>Magnesium for atrial fibrillation after coronary artery bypass
graft surgery: its role in aetiology and prevention</article-title><source>Crit Care Resusc</source><year>2000</year><volume>2</volume><issue>4</issue><fpage>260</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">16597312</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdellatif</surname><given-names>MK</given-names></name><name><surname>Khairy</surname><given-names>MA</given-names></name><name><surname>Mabood</surname><given-names>HA</given-names></name></person-group><article-title>The effects of magnesium sulfate pretreatment on reperfusion
injury after coronary artery bypass graft surgery</article-title><source>Ain-Shams J Anaesthesiol</source><year>2014</year><volume>7</volume><issue>3</issue><fpage>362</fpage><lpage>362</lpage></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speziale</surname><given-names>G</given-names></name><name><surname>Ruvolo</surname><given-names>G</given-names></name><name><surname>Fattouch</surname><given-names>K</given-names></name><name><surname>Macrina</surname><given-names>F</given-names></name><name><surname>Tonelli</surname><given-names>E</given-names></name><name><surname>Donnetti</surname><given-names>M</given-names></name><etal/></person-group><article-title>Arrhythmia prophylaxis after coronary artery bypass grafting:
regimens of magnesium sulfate administration</article-title><source>Thorac Cardiovasc Surg</source><year>2000</year><volume>48</volume><issue>1</issue><fpage>22</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">10757152</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>JV</given-names></name><name><surname>Phillips-Bute</surname><given-names>B</given-names></name><name><surname>McCants</surname><given-names>CB</given-names></name><name><surname>Podgoreanu</surname><given-names>MV</given-names></name><name><surname>Smith</surname><given-names>PK</given-names></name><name><surname>Mathew</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Low serum magnesium level predicts major adverse cardiac events
after coronary artery bypass graft surgery</article-title><source>Am Heart J</source><year>2003</year><volume>145</volume><issue>6</issue><fpage>1108</fpage><lpage>1113</lpage><pub-id pub-id-type="pmid">12796771</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrio</surname><given-names>ML</given-names></name><name><surname>Lopez-Delgado</surname><given-names>JC</given-names></name><name><surname>Javierre</surname><given-names>C</given-names></name><name><surname>Torrado</surname><given-names>H</given-names></name><name><surname>Farrero</surname><given-names>E</given-names></name><name><surname>Rodr&#x000ed;guez-Castro</surname><given-names>D</given-names></name><etal/></person-group><article-title>Magnesium and cardiac surgery in the critical care
setting</article-title><source>Diet Nutrition Critical Care</source><year>2015</year><fpage>459</fpage><lpage>472</lpage></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>MMU</given-names></name><name><surname>Ahsan</surname><given-names>MN</given-names></name><name><surname>Rahman</surname><given-names>MMM</given-names></name><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Hossain</surname><given-names>MM</given-names></name><name><surname>Tauhid-Ul-Mulk</surname><given-names>M</given-names></name><etal/></person-group><article-title>Role of per operative use of intravenous magnesium in reducing
the incidence of per and post operative arrhythmias in conventional coronary
artery bypass graft surgery</article-title><source>J Armed Forces Medical College</source><year>2014</year><volume>9</volume><issue>1</issue><fpage>105</fpage><lpage>114</lpage></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onalan</surname><given-names>O</given-names></name><name><surname>Crystal</surname><given-names>E</given-names></name><name><surname>Daoulah</surname><given-names>A</given-names></name><name><surname>Lau</surname><given-names>C</given-names></name><name><surname>Crystal</surname><given-names>A</given-names></name><name><surname>Lashevsky</surname><given-names>I</given-names></name></person-group><article-title>Meta-analysis of magnesium therapy for the acute management of
rapid atrial fibrillation</article-title><source>Am J Cardiol</source><year>2007</year><volume>99</volume><issue>12</issue><fpage>1726</fpage><lpage>1732</lpage><pub-id pub-id-type="pmid">17560883</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>SA</given-names></name><name><surname>Clyne</surname><given-names>CA</given-names></name><name><surname>Henyan</surname><given-names>N</given-names></name><name><surname>Migeed</surname><given-names>M</given-names></name><name><surname>Yarlagadda</surname><given-names>R</given-names></name><name><surname>Silver</surname><given-names>BB</given-names></name><etal/></person-group><article-title>Impact of magnesium sulfate on serum magnesium concentrations and
intracellular electrolyte concentrations among patients undergoing radio
frequency catheter ablation</article-title><source>Conn Med</source><year>2008</year><volume>72</volume><issue>5</issue><fpage>261</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">18593060</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henyan</surname><given-names>NN</given-names></name><name><surname>Gillespie</surname><given-names>EL</given-names></name><name><surname>White</surname><given-names>CM</given-names></name><name><surname>Kluger</surname><given-names>J</given-names></name><name><surname>Coleman</surname><given-names>CI</given-names></name></person-group><article-title>Impact of intravenous magnesium on post-cardiothoracic surgery
atrial fibrillation and length of hospital stay: a
meta-analysis</article-title><source>Ann Thorac Surg</source><year>2005</year><volume>80</volume><issue>6</issue><fpage>2402</fpage><lpage>2406</lpage><pub-id pub-id-type="pmid">16305929</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Massih</surname><given-names>TE</given-names></name><name><surname>Sarkis</surname><given-names>A</given-names></name><name><surname>Sleilaty</surname><given-names>G</given-names></name><name><surname>Rassi</surname><given-names>I El</given-names></name><name><surname>Chamandi</surname><given-names>C</given-names></name><name><surname>Karam</surname><given-names>N</given-names></name><etal/></person-group><article-title>Myocardial extraction of intracellular magnesium and atrial
fibrillation after coronary surgery</article-title><source>Int J Cardiol</source><year>2012</year><volume>160</volume><issue>2</issue><fpage>114</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">21550673</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alghamdi</surname><given-names>AA</given-names></name><name><surname>Al-Radi</surname><given-names>OO</given-names></name><name><surname>Latter</surname><given-names>DA</given-names></name></person-group><article-title>Intravenous magnesium for prevention of atrial fibrillation after
coronary artery bypass surgery: a systematic review and
meta-analysis</article-title><source>J Card Surg</source><year>2005</year><volume>20</volume><issue>3</issue><fpage>293</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">15854101</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>J</given-names></name><name><surname>Chaudhary</surname><given-names>R</given-names></name><name><surname>Krishnamoorthy</surname><given-names>P</given-names></name><name><surname>Shah</surname><given-names>P</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Bozorgnia</surname><given-names>B</given-names></name></person-group><article-title>Role of prophylactic magnesium supplementation in prevention of
postoperative atrial fibrillation in patients undergoing coronary artery
bypass grafting: a meta-analysis of 23 randomized controlled
trials</article-title><source>J Am Coll Cardiol</source><year>2016</year><volume>67</volume><issue>13S</issue><fpage>689</fpage><lpage>689</lpage></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>S</given-names></name><name><surname>Crystal</surname><given-names>E</given-names></name><name><surname>Garfinkle</surname><given-names>M</given-names></name><name><surname>Lau</surname><given-names>C</given-names></name><name><surname>Lashevsky</surname><given-names>I</given-names></name><name><surname>Connolly</surname><given-names>SJ</given-names></name></person-group><article-title>Effects of magnesium on atrial fibrillation after cardiac
surgery: a meta-analysis</article-title><source>Heart</source><year>2005</year><volume>91</volume><issue>5</issue><fpage>618</fpage><lpage>623</lpage><pub-id pub-id-type="pmid">15831645</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunning</surname><given-names>J</given-names></name><name><surname>Treasure</surname><given-names>T</given-names></name><name><surname>Versteegh</surname><given-names>M</given-names></name><name><surname>Nashef</surname><given-names>SA</given-names></name><collab>EACTS Audit and Guidelines Committee</collab></person-group><article-title>Guidelines on the prevention and management of de novo atrial
fibrillation after cardiac and thoracic surgery</article-title><source>Eur J Cardiothorac Surg</source><year>2006</year><volume>30</volume><issue>6</issue><fpage>852</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">17070065</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LB</surname><given-names>Mitchell</given-names></name><collab>CCS Atrial Fibrillation Guidelines Committee</collab></person-group><article-title>Canadian Cardiovascular Society atrial fibrillation guidelines
2010: prevention and treatment of atrial fibrillation following cardiac
surgery</article-title><source>Can J Cardiol</source><year>2011</year><volume>27</volume><issue>1</issue><fpage>91</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">21329866</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuster</surname><given-names>V</given-names></name><name><surname>Ryd&#x000e9;n</surname><given-names>LE</given-names></name><name><surname>Cannom</surname><given-names>DS</given-names></name><name><surname>Crijns</surname><given-names>HJ</given-names></name><name><surname>Curtis</surname><given-names>AB</given-names></name><name><surname>Ellenbogen</surname><given-names>KA</given-names></name><etal/></person-group><article-title>2011 ACCF/AHA/HRS focused updates incorporated into the
ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial
fibrillation: a report of the American College of Cardiology
Foundation/American Heart Association Task Force on Practice Guidelines
developed in partnership with the European Society of Cardiology and in
collaboration with the European Heart Rhythm Association and the Heart
Rhythm Society</article-title><source>J Am Coll Cardiol</source><year>2011</year><volume>57</volume><issue>11</issue><fpage>e101</fpage><lpage>e198</lpage><pub-id pub-id-type="pmid">21392637</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>M</given-names></name><name><surname>Kut</surname><given-names>MS</given-names></name><name><surname>Icer</surname><given-names>UA</given-names></name><name><surname>Demirtas</surname><given-names>MM</given-names></name></person-group><article-title>Intravenous magnesium sulfate prophylaxis for atrial fibrillation
after coronary artery bypass surgery</article-title><source>J Thorac Cardiovasc Surg</source><year>2003</year><volume>125</volume><issue>2</issue><fpage>344</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">12579104</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>RC</given-names></name><name><surname>Yamashita</surname><given-names>MH</given-names></name><name><surname>Kearns</surname><given-names>M</given-names></name><name><surname>Ramanathan</surname><given-names>K</given-names></name><name><surname>Gin</surname><given-names>K</given-names></name><name><surname>Humphries</surname><given-names>KH</given-names></name></person-group><article-title>Prophylactic magnesium does not prevent atrial fibrillation after
cardiac surgery: a meta-analysis</article-title><source>Ann Thorac Surg</source><year>2013</year><volume>95</volume><issue>2</issue><fpage>533</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">23141526</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name></person-group><article-title>Meta-analysis of randomized controlled trials on magnesium in
addition to beta-blocker for prevention of postoperative atrial arrhythmias
after coronary artery bypass grafting</article-title><source>BMC Cardiovasc Disord</source><year>2013</year><volume>13</volume><fpage>5</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">23343189</pub-id></element-citation></ref></ref-list></back></article>